59 related articles for article (PubMed ID: 20301883)
1. [Does spironolactone use at arterial hypertension therapy protect endothelium also in smoking patients?].
Kara-Perz H; Kosicka T; Perz S
Przegl Lek; 2009; 66(10):571-3. PubMed ID: 20301883
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of selected endocrine parameters in smoking patients with arterial hypertension].
Kara-Perz H; Kosicka T; Perz S
Przegl Lek; 2008; 65(10):514-7. PubMed ID: 19189536
[TBL] [Abstract][Full Text] [Related]
3. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
[TBL] [Abstract][Full Text] [Related]
4. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
5. The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites.
Nevens F; Lijnen P; VanBilloen H; Fevery J
Hepatology; 1996 May; 23(5):1047-52. PubMed ID: 8621132
[TBL] [Abstract][Full Text] [Related]
6. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
Hood SJ; Taylor KP; Ashby MJ; Brown MJ
Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
[TBL] [Abstract][Full Text] [Related]
7. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
[TBL] [Abstract][Full Text] [Related]
8. [Plasma renin activity in essential hypertension: different short- und long-term effects of diuretics (author's transl)].
Esch I; Placheta P; Gaul G
Wien Klin Wochenschr; 1976 Jun; 88(13):415-8. PubMed ID: 824860
[TBL] [Abstract][Full Text] [Related]
9. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
Mahmud A; Mahgoub M; Hall M; Feely J
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
Mahmud A; Feely J
Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
[TBL] [Abstract][Full Text] [Related]
11. [Is hypotensive effectiveness of amlodipine therapy in smokers connected with endothelin-1 (ET-1) concentration?].
Kara-Perz H; Kosicka T; Perz S
Przegl Lek; 2007; 64(10):703-5. PubMed ID: 18409290
[TBL] [Abstract][Full Text] [Related]
12. Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism.
Bernini G; Moretti A; Orlandini C; Berti P; Miccoli P; Bardini M; Taurino C; Bernini M; Salvetti A
J Hypertens; 2008 May; 26(5):981-8. PubMed ID: 18398341
[TBL] [Abstract][Full Text] [Related]
13. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
Skrabal F; Mauser R
Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
[TBL] [Abstract][Full Text] [Related]
14. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
[TBL] [Abstract][Full Text] [Related]
15. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
Papadimitriou M; Vyzantiadis A; Milionis A; Memmos D; Metaxas P
Life Support Syst; 1983; 1(3):197-205. PubMed ID: 6433115
[TBL] [Abstract][Full Text] [Related]
16. The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters.
Kaşifoğlu T; Yalçin AU
Anadolu Kardiyol Derg; 2006 Jun; 6(2):143-7. PubMed ID: 16766279
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine response to cardiac transplantation.
Masters RG; Davies RA; Keon WJ; Walley VM; Koshal A; de Bold AJ
Can J Cardiol; 1993 Sep; 9(7):609-17. PubMed ID: 8221359
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 and adrenomedullin plasma levels after exposure to fludrocortisone, dexamethasone, and spironolactone.
Vogt S; Winkler E; Hermsen D; Schott M; Schinner S; Scherbaum WA; Willenberg HS
Clin Exp Hypertens; 2012; 34(8):582-7. PubMed ID: 22559244
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
Tosti-Croce C; Mantellini R; Fanti P; Sciarra F
Minerva Med; 1983 Apr; 74(14-15):791-7. PubMed ID: 6339999
[TBL] [Abstract][Full Text] [Related]
20. Effect of spironolactone treatment on the renin-aldosterone system during pregnancy.
Lammintausta R; Erkkola R
Int J Clin Pharmacol Biopharm; 1979 Jul; 17(7):294-8. PubMed ID: 489194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
